Sartorius releases the fifth edition of its popular Live-Cell Analysis Handbook 5 October 2021 | By Sartorius AG A comprehensive and interactive digital guide has been released by Sartorius, with real-time, live-cell imaging and analysis including links to application pages, videos and protocols.
Statistical model defines how ketamine anaesthesia affects the brain 4 October 2021 | By Anna Begley (Drug Target Review) An MIT study has used the first statistical model to finely characterise how ketamine anaesthesia affects the brain, possibly improving patient outcomes.
Nobel Prize for medicine awarded to temperature and touch discoveries 4 October 2021 | By Anna Begley (Drug Target Review) David Julius and Ardem Patapoutian have won the 2021 Nobel Prize for Physiology or Medicine, with their work being used to develop treatments for conditions such as chronic pain.
Gene therapy method could restore visual function after stroke 4 October 2021 | By Anna Begley (Drug Target Review) Scientists have revealed a way to use gene therapy to turn glial brain cells into neurons, restoring vision and potentially restoring motor function.
Utilising aquaporins could be the key to repairing corneal defects 1 October 2021 | By Anna Begley (Drug Target Review) New evidence suggests that aquaporin 5 (Aqp5) induction promotes corneal epithelial regeneration, which could lead to possible therapies.
Zaki syndrome: the newly uncovered condition and its potential cure 1 October 2021 | By Anna Begley (Drug Target Review) Dubbed 'Zaki syndrome', the condition affects prenatal development of several organs and was identified using whole genome sequencing.
Psilocybin spurs growth of neural connections lost in depression in vivo 1 October 2021 | By Victoria Rees (Drug Target Review) Research from Yale University has shown that psilocybin, given to mice, triggered an increase in connections between neurons.
Novel class of LPPOs could provide alternative to antibiotics, study shows 30 September 2021 | By Anna Begley (Drug Target Review) Lipophosphonoxins may represent the next generation of antibiotics and can be delivered using a new type of dressing for skin wounds.
New measures to minimise animal testing to be implemented in Europe 30 September 2021 | By Anna Begley (Drug Target Review) The European Medicines Agency is promoting three principles – replace, reduce and refine – to reduce animal testing in medicine development.
CRISPR screening tool exposes new leukaemia drug target 29 September 2021 | By Anna Begley (Drug Target Review) A CRISPR screening tool identified a new target for acute myeloid leukaemia with fewer side effects than current approaches.
Antidepressants inhibit growth of pancreatic and colon cancers in mice 29 September 2021 | By Anna Begley (Drug Target Review) Scientists have discovered that approved antidepressant drugs cause immune cells to recognise and eliminate tumour cells in mouse models.
NINDS awards Sinopia $3.3m for development of Parkinson’s drug candidate 29 September 2021 | By Anna Begley (Drug Target Review) Sinopia has been awarded a $3.3 million Fast-Track SBIR grant to fund the study for its small molecule candidate for Parkinson’s disease.
Scientists uncover mechanisms of potential COVID-19 drug targets 28 September 2021 | By Anna Begley (Drug Target Review) Researchers have used CRISPR and cryogenic electron microscopy to unravel the workings of two receptors involved in diseases such as cancer and COVID-19.
CRISPR-based droplet method speeds up gene therapy research 28 September 2021 | By Anna Begley (Drug Target Review) The new CRISPR-based technology called MIC-Drop rapidly identified several genes for heart development and function in zebrafish.
“Ultrasensitive” HPV detection paves way for precision treatment 28 September 2021 | By Anna Begley (Drug Target Review) A new study sequenced tumour DNA for the “ultrasensitive” detection of HPV, further honing precision treatment of the illness.
